Up­dat­ed: Bris­tol My­ers restarts ra­dio­phar­ma­ceu­ti­cal Phase 3 tri­al

Bris­tol My­ers Squibb has re­sumed re­cruit­ment for its lead ra­dio­phar­ma­ceu­ti­cal tri­al af­ter an iso­tope short­age forced a pause ear­li­er this year, chief med­ical of­fi­cer Samit …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER